From: Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplusassay and their implication for treatment outcomes in patients from Mumbai, India
Sample
INH
RIF
% Concordance
kappa
Onset (n = 88)
86
0.72
94
0.84
5th month (n = 67)
97
0.74
99
0.85
Cumulative (n = 155)
91
0.80
96
0.92